Cumulative incidence of macular edema in non‐infectious uveitis indicates an early therapeutic window
Acta Ophthalmologica · 2025
DOI: 10.1111/aos.17497 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Ophthalmologica, 2025. Verfasst von Bawan Halgurd und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Macular Edema, Uveitis, Registries, Visual Acuity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Roche.
Abstract (Originalsprache)
Purpose
Uveitis‐associated macular edema (UME) is a significant cause of visual impairment in non‐infectious uveitis (NIU). However, the UME incidence remains unclear. Here, we evaluated the cumulative incidence of UME.
Methods
Medical records of patients registered with a uveitis diagnosis code between 2010 and2024 were assessed to validate uveitis diagnoses of the patient registry of the North Denmark Region, a region of 600 000 inhabitants. Positive predictive values (PPV) were calculated for uveitis diagnosis and subtypes. The data from medical records were used to estimate prevalence, incidence and cumulative incidence of UME. The group differences were analysed by chi‐squared test and cox proportional‐hazards model.
Results
A total of 1476 medical records were reviewed. The PPV for a uveitis diagnosis was 92.2% (95% CI: 90.7–93.5) and 88.4% (95% Cl: 86.8–90.0) for uveitis subtypes. Among 1218 patients with NIU, 6.9% had UME at referral. During follow‐up, 8.3% of the NIU patients developed UME with an incidence rate of 1.4 per 100 person‐years (95% CI: 1.3–1.7) and a cumulative incidence of 10.7% (95% CI: 8.5–13.5). A higher incidence of UME was observed for patients with bilateral uveitis, systemic disease, intermediate uveitis, posterior uveitis and panuveitis ( p < 0.001). A substantial increase in the cumulative incidence of UME was observed in the first 2 years post‐referral.
Conclusion
The high PPV supported the registry's reliability for uveitis research. UME was frequently present at the first uveitis clinic visit. NIU patients were at heightened risk of UME within the first 2 years after referral, indicating an early time window with a critical need for inflammation management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Aalborg University Hospital, Aalborg, Denmark.
- Department of Ophthalmology, Rigshospitalet, Glostrup, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- School of Medicine, Vita-Salute, San Raffaele University, Milan, Italy.
- Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Department of Ophthalmology, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Viktor Skalkhøj Oest, Yousif Subhi, Maria Vittoria Cicinelli, Steffen Heegaard
Förderung
- Roche
Zitieren
APA
Halgurd, B., Oest, V. S., Klefter, O. N., Subhi, Y., Cicinelli, M. V., Wied, J., Heegaard, S., Neri, P., Vorum, H., Ørskov, M., & Cehofski, L. J. (2025). Cumulative incidence of macular edema in non‐infectious uveitis indicates an early therapeutic window. Acta Ophthalmologica. https://doi.org/10.1111/aos.17497
Vancouver
Halgurd B, Oest VS, Klefter ON, Subhi Y, Cicinelli MV, Wied J, et al. Cumulative incidence of macular edema in non‐infectious uveitis indicates an early therapeutic window. Acta Ophthalmologica. 2025. doi:10.1111/aos.17497
BibTeX
@article{Halgurd2025,
author = {Halgurd, Bawan and Oest, Viktor Skalkhøj and Klefter, Oliver Niels and Subhi, Yousif and Cicinelli, Maria Vittoria and Wied, Jimmi and Heegaard, Steffen and Neri, Piergiorgio and Vorum, Henrik and Ørskov, Marie and Cehofski, Lasse Jørgensen},
title = {Cumulative incidence of macular edema in non‐infectious uveitis indicates an early therapeutic window},
journal = {Acta Ophthalmologica},
year = {2025},
doi = {10.1111/aos.17497}
}
EUVIMED